Clinical Trials · NCT07755956
Phase Ia Trial of HHK001 Compared With Enantone in Patients With Endometriosis
- Phase
- Phase 1
- Recruitment status
- Recruiting
- Sponsor
- Zhuhai Huahaikang Pharmaceutical Technology Co., Ltd.
- Enrollment
- 20
- Start date
- Oct 2026
- Locations
- 1 site, China
- Primary endpoint
- Concentrations of leuprorelin acetate